However, Yerushalmi et al. observed that ERBB2+ tumors expressing higher total IGF1R protein levels have decreased breast cancer specific survival compared to the lower IGF1R-expressing ERBB2+ counterparts (62). The gene discussed is ERBB2; the disease is breast carcinoma.